Search

You searched for "Genital"

848 results found

Management of stage 1 non-seminomatous germ cell tumours

1 November 2014 | | URO - Urologic Oncology
Testicular cancer (TC) is the most successfully treated solid tumour, achieving a cure rate of 90-95% [1-3]. Testicular cancer is relatively rare with an incidence of 2207 cases in the UK in 2014 [4] and yet is the most common...
An Insider’s Perspective of Prostate Cancer book cover image.

An Insider’s Perspective of Prostate Cancer – Understanding Effects, Management Options and Consequences

27 April 2023 | | URO - Urologic Oncology
This deceptively small paperback punches way above its weight compared to some of the existing hefty tomes on prostate cancer. It is an admirable effort at delivering content pitched at both the lay reader as well as the medical graduate....

Renal stones: an American perspective

1 November 2016 | | URO - Endourology & Stones
This study is from Dallas, USA and appears on the front cover of the BMJ. About 1 in 11 people will have a kidney stone at some point in their lifetime. There is a linear increase in stone prevalence in...

Rectal swab testing before prostate biopsy

1 May 2016 | | URO - Urologic Oncology
This study explored the real terms value of rectal swab testing and targeted antibiotic prophylaxis in patients undergoing transrectal ultrasound prostate biopsy in view of increasing bacterial resistance to fluoroquinolones (17.6% in North America, 40% in Hong Kong). The authors...

Birmingham Women’s Hospital praises image quality, system usability and ease of patient access of Ultimax-i

25 May 2023 | Company Profiles, Contracts & Distributors, Research & Development
Female fluoroscopy procedures including Hysterosalpingography (HSG) to assess uterine cavity and fallopian tubes, as well as video...

June Medical’s Angela Spång wins top award at Goldman Sachs 10KSB

20 March 2025
After a rigorous application and interview process, Angela Spång, Founder & Owner of award-winning medical device company, June Medical, secured a place on the Goldman Sachs 10KSB transformative programme. She embarked on what is considered to be a condensed mini...

Radiology quiz

1 March 2017 | | URO - Uroradiology
We are delighted to introduce something new for the Uroradiology Focus – our very own Jane Belfield has put together a urology imaging quiz with 10 cases designed to grab your interest and test your knowledge. Good luck and let...

What exactly is Hinman Syndrome?

1 September 2019 | | URO - Neurourology, URO - Functional / Reconstructive Urology
Who was Hinman and what is Hinman Syndrome? Frank Hinman Junior (1915–2011) first described ‘Hinman syndrome’ in the 1970s – a condition also known as a ‘non-neurogenic neurogenic bladder’. He was a renowned American urologist, educator and skilful artist and...

In conversation with Matthew Bultitude

27 November 2025 | URO - Core Urology
Matthew Bultitude. Can you tell us a little bit about what led you into the field of urology and what have been the highlights so far? Thank you and that is a very interesting question given that my father was...

Focal therapy trials

6 November 2020 | | URO - Urologic Oncology
Men with localised prostate cancer have traditionally required whole gland treatment involving radical prostatectomy or radical radiation treatment, independent of disease location and size. Increasing evidence supports the use of active treatment only in those men diagnosed with prostate cancer...

The conservative assessment and treatment of mixed urinary and anal incontinence in women: a multidisciplinary approach

1 September 2019 | | URO - Functional / Reconstructive Urology, URO - Neurourology
Mixed urinary incontinence Urinary incontinence (UI) is considered to be a highly prevalent condition; however, depending upon the definitions used, actual reported prevalence rates can vary significantly. The International Consultation on Incontinence (ICI) review [1], reported unadjusted prevalence estimates for...

Prostate cancer

8 November 2021 | | URO - Urologic Oncology
Case 1 A 65-year-old man is referred to your two-week wait (2WW) clinic with a PSA of 7.0ng/mL. He has no lower urinary tract symptoms (LUTS), no past medical history, no family history of prostate cancer (PCa) and his performance...